Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation

Transplant Proc. 1999 Nov;31(7A):37S-40S. doi: 10.1016/s0041-1345(99)00792-7.
No abstract available

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Antilymphocyte Serum / therapeutic use*
  • Cyclosporine / therapeutic use
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / drug therapy*
  • Graft Rejection / mortality
  • Graft Survival*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Male
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Muromonab-CD3 / therapeutic use*
  • Reoperation
  • Retrospective Studies
  • Survival Rate
  • Tacrolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Tacrolimus
  • Methylprednisolone